Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeneCapture is a private U.S. diagnostics company developing a portable, point-of-care platform for rapid pathogen identification and antimicrobial susceptibility testing. Its CAPTURE Platform is designed to move from patient sample to actionable treatment guidance in roughly 1-2 hours without central-lab infrastructure, refrigeration, or highly trained technical staff. The company uses direct RNA hybridization, optical sensing, disposable cartridges, and onboard sample preparation to detect bacteria, viruses, fungi, and parasites. GeneCapture markets the technology for healthcare, military, rural, agricultural, and other austere-use settings where fast infectious disease decision-making is critical. The company is based at the HudsonAlpha Institute for Biotechnology campus in Huntsville, Alabama and appears to be advancing toward commercialization rather than running a traditional therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeneCapture.